These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3866686)

  • 1. [Busulfan and eye complications].
    Tuppurainen K; Nousiainen T; Lahtinen R
    Duodecim; 1985; 101(24):2420-2. PubMed ID: 3866686
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
    Larrain C; Cruz A; Codoceo V
    Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227
    [No Abstract]   [Full Text] [Related]  

  • 3. [Survival of 29 cases of chronic myeloid leukemia treated by myleran].
    Petitclerc C; Barry A
    Union Med Can; 1976 Feb; 105(2):210-6. PubMed ID: 1069396
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed toxic effect of busulfan on the marrow.
    Ganda OP; Mangalik A
    J Assoc Physicians India; 1973 Jun; 21(6):511-6. PubMed ID: 4525264
    [No Abstract]   [Full Text] [Related]  

  • 5. Busulfan lung: cytologic diagnosis.
    Dalri P; Piscioli F; Detassis C
    Haematologica; 1980 Aug; 65(4):469-74. PubMed ID: 6774919
    [No Abstract]   [Full Text] [Related]  

  • 6. Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan.
    Comhaire F; Van Hove W; Van Ganse W; Van der Straeten M
    Scand J Respir Dis; 1972; 53(5):265-73. PubMed ID: 4508954
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of busulfan-treated granulocytic leukemia on pregnancy, labor and the somatic condition of the newborn infant].
    Szmigiel Z; Kowalska J; Szczepaniak AM
    Przegl Lek; 1986; 43(9):632-4. PubMed ID: 3468559
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy of chronic myelocytic leukemia.
    Galton DA
    Semin Hematol; 1969 Oct; 6(4):323-43. PubMed ID: 4900650
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of chronic myeloid leukemia with dibromomannitol].
    Clément F; Saillen R
    Schweiz Med Wochenschr; 1970 Nov; 100(46):1995-7. PubMed ID: 5279364
    [No Abstract]   [Full Text] [Related]  

  • 10. [Observations on the terminal course of chronic myeloid leukemia treated by alkylating agents (busulfan)].
    Giovanelli E
    Minerva Med; 1970 May; 61(37):2038-41. PubMed ID: 4097050
    [No Abstract]   [Full Text] [Related]  

  • 11. [Busulfan-induced adrenal insufficiency].
    Rodríguez Cuartero A; Durán Cara E; Peláez Redondo J
    Rev Clin Esp; 1973 Oct; 131(1):73-8. PubMed ID: 4520013
    [No Abstract]   [Full Text] [Related]  

  • 12. [Busulfan lung. Pulmonary fibrosis caused by Myleran].
    Koch H; Lesch R
    Med Welt; 1976 Feb; 27(7):308-11. PubMed ID: 1062649
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pulmonary alveolar fibrosis caused by Myleran (busulfan)].
    Etcheberry R; Becker P; Delmastro J; Donoso S
    Rev Med Chil; 1973 Jan; 101(1):42-6. PubMed ID: 4518637
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic sialadenitis. A toxic effect of prolonged busulfan therapy for chronic myelogenous leukaemia (author's transl)].
    Morales Polanco MR; Butron L; Echegoyen G; Pizzuto Chavez J
    Sangre (Barc); 1977; 22(2):243-51. PubMed ID: 266289
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reversible pituitary-adrenal insufficiency produced by busulfan].
    García-San Miguel J; Pujol-Moix N
    Rev Clin Esp; 1968 Sep; 110(5):467-72. PubMed ID: 4247382
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fatal pulmonary fibrosis, with cellular lesions of the lung and pancreas, attributed to busulfan].
    Batzenschlager A; Oberling F; Guerbaoui M; Vetter JM
    Arch Anat Pathol (Paris); 1972 Sep; 20(3):291-4. PubMed ID: 4507846
    [No Abstract]   [Full Text] [Related]  

  • 17. Histopathology and ultrastructure of busulfan-induced cataract.
    Hamming NA; Apple DJ; Goldberg MF
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1976 Aug; 200(2):139-47. PubMed ID: 1086604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serious hematological accidents due to Myleran in the treatment of chronic myeloid leukemia].
    Olmer J; Muratore R; Gabriel B; Canu AM
    Mars Med; 1968; 105(4):330-8. PubMed ID: 5245481
    [No Abstract]   [Full Text] [Related]  

  • 19. [Degenerative retinal conditions after treatment with Busulfan during pregnancy (author's transl)].
    Saraux H; Lefrancois A
    Klin Monbl Augenheilkd; 1977 Jun; 170(6):818-20. PubMed ID: 268448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Toxic effects of busulfan (myleran) in the treatment of chronic myeolid leukemia].
    Japp H
    Schweiz Med Wochenschr; 1974 Aug; 104(32):1115-9. PubMed ID: 4548568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.